Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Bethesda North Marriott Hotel and Conference Center

20 sep 2018 7:00 a.m. - 21 sep 2018 12:45 p.m.

5701 Marinelli Road, , North Bethesda, MD 20852 , USA

Advancing the Science of Study Endpoints

Session 8: The Emerging Role of Novel Devices in Collecting Real-Time Data

Session Chair(s)

Keith  Wenzel

Keith Wenzel

Volunteer

DIA Study Endpoints Community, United States

Within clinical trials, there is optimism that connected medical devices can be used to collect novel endpoints, to give greater insight into a study subject’s health status, to provide benefits of investigational products, and to further the understanding of the safety and efficacy of investigational products. There is also some hesitancy around connected sensors, however, due to the lack of formal guidance from regulatory authorities. The challenge today is not deciding on whether to use a mobile health device, but rather the effective integration of the device into the study. This session will explore the current state of the science for connected medical devices to collect meaningful study endpoints in clinical trials.

Learning Objective : Upon completion of this session, participants should be able to:
  • Describe the current state of the science when using medical devices to collect study outcomes
  • Describe the lessons learned from real-world use of medical devices in clinical trials

Speaker(s)

Michael  King

Exploration of Six Sensing Devices as Study Endpoints

Michael King

Sanofi, United States

Senior Director, Diabetes Project Leader

Martin  Ho, PhD, MS

A Regulator’s Perspective on Novel Endpoints and Patient Preferences in Medical Devices

Martin Ho, PhD, MS

Google, United States

Head of Biostatistics

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.